Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Breast 1

Conditions

Breast Neoplasms 7Drug-Related Side Effects and Adverse Reactions 1

Interventions

Cyclophosphamide 3Pyridoxine 2Amifostine 2trastuzumab deruxtecan 1sodium thiosulfate 1sargramostim 1sacituzumab govitecan 1eribulin 1Triptorelin Pamoate 1Trastuzumab 1Thiotepa 1Social Determinants of Health 1Radiotherapy 1Pregabalin 1Peripheral Blood Stem Cell Transplantation 1Mitoxantrone 1Methotrexate 1Furosemide 1Etoposide 1Epoetin Alfa 1Duloxetine Hydrochloride 1Drug Therapy 1Doxorubicin 1Dihydrouracil Dehydrogenase (NADP) 1Cisplatin 1Chemotherapy, Adjuvant 1Celecoxib 1Carboplatin 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Drug-Related Side Effects and Adverse Reactions × Mitoxantrone × Breast × Clear all
NCT00003068 2013-01-31

High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer

National Cancer Institute (NCI)

Phase 2 Completed
30 enrolled
Breast

Breast Neoplasms, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡